UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002215
Receipt number R000002720
Scientific Title Randomized phase II study with six cycles of Docetaxel/cyclophosphamide (TC) and 5-fluorouracil, epirubicin, and cyclophosphamide (FEC100) followed by docetaxel for treating hormone receptor-negative breast cancers
Date of disclosure of the study information 2009/07/17
Last modified on 2019/07/16 13:35:15

No. Disposal Last modified on Item of update
1 Insert 2009/07/16 16:30:20
2 Update 2009/12/25 09:30:17 Recruitment status
3 Update 2010/03/03 19:13:03 Organization1
4 Update 2010/07/20 13:33:16 Address
Address
5 Update 2010/07/20 13:36:35 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
6 Update 2011/02/09 14:07:05 Target sample size
7 Update 2011/02/10 08:55:53 Key inclusion criteria
Key inclusion criteria
8 Update 2012/06/01 17:22:44 Post marketing survey by drug manufacture etc., specified by Japanese law.
9 Update 2012/06/01 17:23:04 Recruitment status
10 Update 2013/01/18 09:54:10 Last follow-up date
11 Update 2013/04/02 15:12:58 Email
12 Update 2013/07/24 10:35:50 Publication of results
Results
Other related information
Other related information
13 Update 2014/01/17 11:17:52 Email
Organization
Organization
14 Update 2014/01/17 11:18:18 Results
15 Update 2015/01/23 09:36:30 Name of person sending information
Name of person sending information
16 Update 2019/07/16 13:35:15 Recruitment status
Date of IRB